Long term toxicity and tolerance of concurrent docetaxel with radiotherapy in cisplatin-ineligible head and neck cancer patients

Oral Oncol. 2022 Jul:130:105908. doi: 10.1016/j.oraloncology.2022.105908. Epub 2022 May 27.

Affiliations

¹ Department of Medical Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
² Department of Radiation Oncology, Tata Memorial Hospital, HBNI, Mumbai, India.
³ Department of Medical Oncology, Tata Memorial Hospital, HBNI, Mumbai, India. Electronic address: [email protected].

PMID: 35636079
DOI: 10.1016/j.oraloncology.2022.105908

No abstract available

Publication types

Letter

MeSH terms

Antineoplastic Combined Chemotherapy Protocols / adverse effects
Carcinoma, Squamous Cell* / drug therapy
Chemoradiotherapy / adverse effects
Cisplatin / adverse effects
Docetaxel / adverse effects
Fluorouracil / therapeutic use
Head and Neck Neoplasms* / drug therapy
Head and Neck Neoplasms* / radiotherapy
Humans

Substances

Docetaxel
Cisplatin
Fluorouracil